Amplify Weight Loss Drug & Treatment ETF (THNR)

THNR Holdings Information

THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Novo Nordisk stock at 13.32%, Eli Lilly and Company at 12.91%, OTHER ASSETS AND LIABILITIES at 12.01%, Regeneron Pharmaceuticals at 6.84%, and Amgen at 6.79%.

• Total Holdings: 23
• Top 10 Percentage: 78.24%
• Asset Class: Equity
• ETF Category: Health
• Assets: 3.91M
• PE Ratio: 19.79

Top 25 Holdings

As of Jan 7, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	NVO	Novo Nordisk A/S	13.32%	9,277
2	LLY	Eli Lilly and Company	12.91%	459
3	n/a	OTHER ASSETS AND LIABILITIES	12.01%	121,721,947
4	REGN	Regeneron Pharmaceuticals, Inc.	6.84%	332
5	AMGN	Amgen Inc.	6.79%	783
6	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	6.26%	4,600
7	MRK	Merck & Co., Inc.	5.19%	1,882
8	SWX: ROG	Roche Holding AG	5.01%	465
9	AZN	AstraZeneca PLC	4.98%	2,064
10	HKG: 1801	Innovent Biologics, Inc.	4.93%	17,000
11	TYO: 4507	Shionogi & Co., Ltd.	4.93%	10,700
12	ABBV	AbbVie Inc.	4.92%	830
13	PFE	Pfizer Inc.	4.64%	7,235
14	HKG: 1093	CSPC Pharmaceutical Group Limited	4.04%	136,000
15	ARWR	Arrowhead Pharmaceuticals, Inc.	3.78%	2,267
16	HIMS	Hims & Hers Health, Inc.	3.31%	3,679
17	CPH: ZEAL	Zealand Pharma A/S	1.92%	1,143
18	VKTX	Viking Therapeutics, Inc.	1.62%	1,974
19	SRRK	Scholar Rock Holding Corporation	1.60%	1,425
20	JNGHF	Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H	1.01%	4,000
21	KRX: 128940	Hanmi Pharm. Co., Ltd.	0.89%	109
22	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.59%	23,126
23	n/a	US DOLLARS	-11.49%	452,607